Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DeepWise / 深睿医疗

Request full access

Full-scenario medical imaging AI and multimodal digital healthcare platforms

Haidian, ChinaFounded 2017Health Tech & Medtech

About DeepWise / 深睿医疗

DeepWise (深睿医疗) is a China medical imaging AI company founded in 2017. It builds full-workflow radiology AI platforms such as DeepWise MetAI and multimodal hospital data products (TrioData), covering screening, diagnosis, clinical decision support, research and training. The company holds multiple NMPA Class III certificates and serves thousands of medical institutions. Official addresses include Haidian District in Beijing plus Shanghai Xuhui and Hangzhou Yuhang offices; recent financing was co-led by Legend Capital and Hangzhou industrial funds.

Source: Dealroom company data

At a glance

Status
Operational
Employees
55
Open positions
2
Dealroom signal
75.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Oncology, Hard Tech, DT and LS, science-based
Technology
Artificial Intelligence, Deep Tech, Machine Learning, Computer Vision
Client focus
B2B

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing Mar 2026 $200M $800M Kaitai Capital · CDH Investments · HongShan · Jinyi Capital ↗
SERIES DOther financing Jan 2025 $69M $688M Hangzhou Yuhang Financial Holding Group · Legend Capital ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Growth signals

DeepWise / 深睿医疗 website traffic

Latest recorded traffic for DeepWise / 深睿医疗 is 1.2K monthly website visits, down 76.5% over the last three months. DeepWise / 深睿医疗's team grew 0% over the past year.

Latest monthly visits1.2K 3-month web change-76.5% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
InterVennCombines next generation epiproteomics, instrumentation, and deep learning to augment cancer diagnosis, biomarker, and target discovery South San Francisco, United States Operational 50 $244M $804M
SHINE TechnologiesDeploying and scaling near-term applications of fusion technology that we hope will one day lead to powering the world Janesville, United States Operational
Delfi DiagnosticsDetects cancer early, when it is most curable, using high precision non-invasive blood tests Baltimore, United States Operational
Odyssey TherapeuticsBuilding a machine learning-based platform to develop novel therapeutics focusing on cancer and autoimmune diseases Boston, United States Operational
Soley TherapeuticsDrug discovery and development company using cellular responses and AI to identify novel therapies for complex diseases Brentwood, United States Operational
Antares TherapeuticsDevelopment of precision oncology therapies, utilizing acquired discovery capabilities and a validated pipeline for patient treatments Boston, United States Operational
Callio TherapeuticsBiotechnology firm advancing multi-payload ADCs for targeted cancer therapy with innovative HER2 solutions Seattle, United States Operational
Avistone PharmaceuticalsDeveloping cancer therapies China Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

DeepWise / 深睿医疗 in the Haidian ecosystem

Live from Dealroom

The DeepWise / 深睿医疗 office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • FengHe Group
  • DHVC (Danhua Capital)

Series B and later9 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
3 countries with
team presence
🇨🇳 China92.3%
🇺🇸 United States5.1%
🇸🇬 Singapore2.6%
3 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DeepWise / 深睿医疗 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DeepWise / 深睿医疗’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.